The first COPD patient has been dosed in a Phase 1b COPD trial testing Bambusa Therapeutics’ dual-target therapy BBT002.

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

Miami (August 28, 2025) – Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved ...

Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved standardization of care, ...

Healio Pulmonology has compiled the top news on COPD posted in 2025.Readers were most interested in how pulmonary ...

Nonmedication COPD strategies, such as pulmonary rehabilitation, are highlighted. Jeffrey D. Dunn, PharmD, MBA: [Summarize] the nonmedication strategies that we can use to optimize the management of ...

Researchers used integrated genomics to identify convergent transcriptomic pathways in emphysema and IPF. Convergent transcriptional regulatory networks in diseases such as chronic obstructive ...

Newly published observations in patients and experiments in mice provide evidence that cigarette smoke reduces expression of the protein NLRX1 in the lung, taking the restraints off a destructive ...

Pulmonary hypertension is an unremitting disease caused by a progressive increase in blood pressure in the blood vessels of the lung; it leads to heart failure and ultimately death. Currently there ...

—The 2019 GOLD guidelines emphasize the need for separate strategies for initial and follow-up pharmacotherapy and the importance of using of eosinophil counts to decide about inhaled corticosteroid ...